Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Clinical significance of apoptosis-associated speck-like protein containing a caspase recruitment domain in oral squamous cell carcinoma.

Shimane T, Kobayashi H, Takeoka M, Kitazawa M, Matsumura T, Hida S, Xiao T, Koike T, Taniguchi S, Kurita H.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jun;115(6):799-809. doi: 10.1016/j.oooo.2013.03.013.

PMID:
23706920
[PubMed - indexed for MEDLINE]
2.

High expression of EZH2 is associated with tumor proliferation and prognosis in human oral squamous cell carcinomas.

Kidani K, Osaki M, Tamura T, Yamaga K, Shomori K, Ryoke K, Ito H.

Oral Oncol. 2009 Jan;45(1):39-46. doi: 10.1016/j.oraloncology.2008.03.016. Epub 2008 Jul 10.

PMID:
18619895
[PubMed - indexed for MEDLINE]
3.

Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.

Su L, Wang Y, Xiao M, Lin Y, Yu L.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):484-91. doi: 10.1016/j.tripleo.2010.04.009.

PMID:
20868995
[PubMed - indexed for MEDLINE]
4.

Is expression of p120ctn in oral squamous cell carcinomas a prognostic factor?

Lo Muzio L, Pannone G, Santarelli A, Bambini F, Mascitti M, Rubini C, Testa NF, Dioguardi M, Leuci S, Bascones A, Reynolds AB, Mariggiò MA.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Jun;115(6):789-98. doi: 10.1016/j.oooo.2013.03.006.

PMID:
23706919
[PubMed - indexed for MEDLINE]
Free Article
5.

Loss of keratin 8 phosphorylation leads to increased tumor progression and correlates with clinico-pathological parameters of OSCC patients.

Alam H, Gangadaran P, Bhate AV, Chaukar DA, Sawant SS, Tiwari R, Bobade J, Kannan S, D'cruz AK, Kane S, Vaidya MM.

PLoS One. 2011;6(11):e27767. doi: 10.1371/journal.pone.0027767. Epub 2011 Nov 17.

PMID:
22114688
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.

Cheng AN, Jiang SS, Fan CC, Lo YK, Kuo CY, Chen CH, Liu YL, Lee CC, Chen WS, Huang TS, Wang TY, Lee AY.

Cancer Lett. 2013 Sep 1;337(2):218-25. doi: 10.1016/j.canlet.2013.05.008. Epub 2013 May 16.

PMID:
23684929
[PubMed - indexed for MEDLINE]
7.

Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.

Yoshizawa K, Nozaki S, Kitahara H, Kato K, Noguchi N, Kawashiri S, Yamamoto E.

Oncol Rep. 2011 Dec;26(6):1555-60. doi: 10.3892/or.2011.1419. Epub 2011 Aug 10.

PMID:
21833477
[PubMed - indexed for MEDLINE]
8.

High LC3 expression correlates with poor survival in patients with oral squamous cell carcinoma.

Tang JY, Hsi E, Huang YC, Hsu NC, Chu PY, Chai CY.

Hum Pathol. 2013 Nov;44(11):2558-62. doi: 10.1016/j.humpath.2013.06.017. Epub 2013 Sep 20.

PMID:
24055091
[PubMed - indexed for MEDLINE]
9.

Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma.

Fang FM, Li CF, Huang HY, Lai MT, Chen CM, Chiu IW, Wang TL, Tsai FJ, Shih IeM, Sheu JJ.

Am J Pathol. 2011 May;178(5):2407-15. doi: 10.1016/j.ajpath.2011.01.043.

PMID:
21514451
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system.

Tokman B, Gultekin SE, Sezer C, Alpar R.

Saudi Med J. 2004 Dec;25(12):1922-30.

PMID:
15711668
[PubMed - indexed for MEDLINE]
11.

Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.

Bose P, Klimowicz AC, Kornaga E, Petrillo SK, Matthews TW, Chandarana S, Magliocco AM, Brockton NT, Dort JC.

BMC Cancer. 2012 Aug 1;12:332. doi: 10.1186/1471-2407-12-332.

PMID:
22852863
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Overexpression of SENP5 in oral squamous cell carcinoma and its association with differentiation.

Ding X, Sun J, Wang L, Li G, Shen Y, Zhou X, Chen W.

Oncol Rep. 2008 Nov;20(5):1041-5.

PMID:
18949399
[PubMed - indexed for MEDLINE]
13.

Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan.

Cheng SJ, Lee JJ, Kok SH, Chou CH, Chang HH, Yang H, Chiang ML, Kuo MY.

J Formos Med Assoc. 2011 Jan;110(1):50-7. doi: 10.1016/S0929-6646(11)60008-9.

PMID:
21316013
[PubMed - indexed for MEDLINE]
14.

Angiopoietin-2 expression is correlated with angiogenesis and overall survival in oral squamous cell carcinoma.

Li C, Sun CJ, Fan JC, Geng N, Li CH, Liao J, Mi K, Zhu GQ, Ma H, Song YF, Tang YL, Chen Y.

Med Oncol. 2013;30(2):571. doi: 10.1007/s12032-013-0571-2. Epub 2013 May 7.

PMID:
23649549
[PubMed - indexed for MEDLINE]
15.

Effects of FasL expression in oral squamous cell cancer.

Fang L, Sun L, Hu FF, Chen QE.

Asian Pac J Cancer Prev. 2013;14(1):281-5.

PMID:
23534738
[PubMed - indexed for MEDLINE]
Free Article
16.

Annexin A1 down-regulation in oral squamous cell carcinoma correlates to pathological differentiation grade.

Zhu DW, Yang X, Yang CZ, Ma J, Liu Y, Yan M, Wang LZ, Li J, Zhang CP, Zhang ZY, Zhong LP.

Oral Oncol. 2013 Jun;49(6):542-50. doi: 10.1016/j.oraloncology.2013.01.002. Epub 2013 Feb 9.

PMID:
23403091
[PubMed - indexed for MEDLINE]
17.

Analysis of cell proliferation and pattern of invasion in oral squamous cell carcinoma.

Watanabe S, Watanabe R, Oton-Leite AF, Alencar Rde C, Oliveira JC, Leles CR, Batista AC, Mendonça EF.

J Oral Sci. 2010 Sep;52(3):417-24.

PMID:
20881335
[PubMed - indexed for MEDLINE]
Free Article
18.

Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome.

Jiang Q, Pan HY, Ye DX, Zhang P, Zhong LP, Zhang ZY.

Tumour Biol. 2010 Oct;31(5):451-9. doi: 10.1007/s13277-010-0054-4. Epub 2010 Jun 8.

PMID:
20532727
[PubMed - indexed for MEDLINE]
19.

Midkine expression is correlated with an adverse prognosis and is down-regulated by p53 in oral squamous cell carcinoma.

Ota K, Fujimori H, Ueda M, Jono H, Shinriki S, Ota T, Sueyoshi T, Taura M, Taguma A, Kai H, Shinohara M, Ando Y.

Int J Oncol. 2010 Oct;37(4):797-804.

PMID:
20811700
[PubMed - indexed for MEDLINE]
20.

Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance.

Imai Y, Sasaki T, Shinagawa Y, Akimoto K, Fujibayashi T.

Oral Oncol. 2002 Sep;38(6):557-61.

PMID:
12167433
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk